Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations

NCT04672642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of the study is to assess the efficacy of the SpyGlass DS for the detection of residual pancreatic calculations after endoscopic treatment.

Conditions

  • Pancreatitis, Chronic

Interventions

DEVICE

SpyGlass DS

Detection by the SpyGlass DS of residual pancreatic stones not detected by the standard method (CT scan and ERCP)

Sponsors & Collaborators

  • Hospital St. Joseph, Marseille, France

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-12
Primary Completion
2024-03-13
Completion
2024-03-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04672642 on ClinicalTrials.gov